Literature DB >> 35102073

PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction.

Elise Miller1, Charles Norwood1, Jason B Giles1, Rachel Huddart2, Jason H Karnes1,3, Michelle Whirl-Carrillo2, Teri E Klein2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35102073      PMCID： PMC8988468          DOI： 10.1097/FPC.0000000000000465

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  69 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia.

Authors:  J K Burgess; R Lindeman; C N Chesterman; B H Chong
Journal:  Br J Haematol       Date:  1995-11       Impact factor: 6.998

3.  Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells.

Authors:  J W Choi; S Y Lee; Y Choi
Journal:  Cell Immunol       Date:  1996-02-25       Impact factor: 4.868

4.  Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia.

Authors:  Lubica Rauova; Mortimer Poncz; Steven E McKenzie; Michael P Reilly; Gowthami Arepally; John W Weisel; Chandrasekaran Nagaswami; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

5.  Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.

Authors:  Scarparo Pamela; Lombardi Anna Maria; Duner Elena; Malerba Giovanni; Allemand Emanuele; Vettore Silvia; Blumentritt Carmen; Greinacher Andreas; Fabris Fabrizio
Journal:  Platelets       Date:  2012-07-13       Impact factor: 3.862

Review 6.  Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.

Authors:  Dennis McGonagle; Gabriele De Marco; Charles Bridgewood
Journal:  J Autoimmun       Date:  2021-05-19       Impact factor: 7.094

7.  The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.

Authors:  Derek W Linskey; David C Linskey; Howard L McLeod; Jasmine A Luzum
Journal:  Pharmacogenomics       Date:  2021-10-05       Impact factor: 2.638

8.  Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery.

Authors:  Zaishen Jia; Ganzhong Tian; Yupeng Ren; Zhiquan Sun; Wei Lu; Xiaotong Hou
Journal:  J Transl Med       Date:  2015-02-01       Impact factor: 5.531

Review 9.  Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Authors:  Maureen A Smythe; Jennifer Priziola; Paul P Dobesh; Diane Wirth; Adam Cuker; Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.

Authors:  Ishac Nazy; Stefan D Jevtic; Jane C Moore; Angela Huynh; James W Smith; John G Kelton; Donald M Arnold
Journal:  J Thromb Haemost       Date:  2021-03-14       Impact factor: 16.036
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.